• Phare
  • Validé par KD/KO

Anticorps Recombinant de lapin anti-TDP-43 (N-terminal)

TDP-43 (N-terminal) Recombinant Antibody for WB, IHC, IHC-Autostainer, IF/ICC, IF-P, FC (Intra), IP, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

WB, IHC, IHC-Autostainer, IF/ICC, IF-P, FC (Intra), IP, ELISA

Conjugaison

Non conjugué

Publications(5)

CloneNo.

16A22

N° de cat : 80002-1-RR

Synonymes

TDP-43 (for IF/FC), TARDBP, TDP 43, TDP43, TDP-43



Applications testées

Résultats positifs en WBcellules HeLa, cellules C6, cellules K-562, cellules Neuro-2a
Résultats positifs en IPHAP1 cells, cellules HeLa
Résultats positifs en IHC-Autostainertissu cérébral humain,
Résultats positifs en IHCtissu cérébral de souris, tissu cérébral humain
il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
Résultats positifs en IF-Ptissu cérébral de rat,
Résultats positifs en IF/ICCcellules HeLa, cellules HepG2, cellules SH-SY5Y
Résultats positifs en FC (Intra)cellules HeLa

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:5000-1:50000
Immunoprécipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochimie (IHC)-AUTOSTAINERIHC-AUTOSTAINER : 1:50-1:500
Immunohistochimie (IHC)IHC : 1:1600-1:6400
Immunofluorescence (IF)-PIF-P : 1:800-1:3200
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

80002-1-RR cible TDP-43 (N-terminal) dans les applications de WB, IHC, IHC-Autostainer, IF/ICC, IF-P, FC (Intra), IP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Réactivité citéeHumain, souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène TDP-43 (N-terminal) Protéine recombinante Ag1231
Nom complet TAR DNA binding protein
Masse moléculaire calculée 43 kDa
Poids moléculaire observé 43 kDa
Numéro d’acquisition GenBankBC001487
Symbole du gène TDP-43
Identification du gène (NCBI) 23435
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

The TARDBP gene encodes the TDP-43 protein, initially found to repress HIV-1 transcription by binding TAR DNA. TDP-43 has since been shown to bind RNA as well as DNA, and have multiple functions in transcriptional repression, translational regulation and pre-mRNA splicing. For instance, it is reported to regulate alternate splicing of the CTFR gene. In 2006 Neumann et al. found that hyperphosphorylated, ubiquitinated and/or cleaved forms of TDP-43, collectively known as pathological TDP-43, play a major role in the disease mechanisms of ubiquitin-positive, tau- and alpha-synuclein-negative frontotemporal dementia (FTLD-U) and in amyotrophic lateral sclerosis (ALS). Proteintech's 80002-1-RR is a rabbit recombinant TDP-43 antibody recognizing N-terminal TDP-43. It recognizes the intact 43 kDa protein as well as all posttranslationally modified and truncated forms in multiple applications. Various forms of TDP-43 exist, including 18-35 kDa of cleaved C-terminal fragments, 45-50 kDa phospho-protein, 55 kDa glycosylated form, 75 kDa hyperphosphorylated form, and 90-300 kDa cross-linked form. (PMID: 17023659, 19823856, 21666678, 22193176) Recently TDP-43 has been reported to be overexpressed in triple negative breast cancer (TNBC) and it may be a potential target for TNBC diagnosis and drug design. (PMID: 29581274)

80002-1-RR antibody works well in IF experiment.

Protocole

Product Specific Protocols
WB protocol for TDP-43 (N-terminal) antibody 80002-1-RRDownload protocol
IHC protocol for TDP-43 (N-terminal) antibody 80002-1-RRDownload protocol
IF protocol for TDP-43 (N-terminal) antibody 80002-1-RRDownload protocol
IP protocol for TDP-43 (N-terminal) antibody 80002-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

bioRxiv

Patient-derived Induced Pluripotent Stem Cells as a Model to Study Frontotemporal Dementia Pathologies

Authors - Sonia Infante-Tadeo
humanIF

Nat Chem Biol

Small-molecule dissolution of stress granules by redox modulation benefits ALS models

Authors - Hiroyuki Uechi
mouseWB,IF

Neural Regen Res

5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis

Authors - Shi-Shi Jiang
humanWB,IP,IF

F1000Res

The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence

Authors - Donovan Worrall
humanIHC

J Neuropathol Exp Neurol

COVID-19 could worsen cerebral amyloid angiopathy

Authors - Julie Dewisme
{{ptg:RelatedPrimaryAntibodies}}